Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Epotec

Explore full profile

A provider of Internet-based behavioral health services

Wilmington, United StatesFounded 1997Health Tech & Medtech
Valuation $50–100M Last recorded · 1999
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Epotec and the history behind them.

About Epotec

Epotec is the brand name for the epoxy resins business of Aditya Birla Chemicals, a major division within the global conglomerate Aditya Birla Group. The brand operates under the Advanced Materials business unit, which is a significant player in the worldwide epoxy resin market. Commercial production of Epotec resins began in 1992, initially focused on serving the Southeast Asia region. The business is part of Aditya Birla Chemicals (Thailand) Ltd. and also operates state-of-the-art manufacturing plants in India, with a global presence that includes offices in Germany and the USA.

The history of the parent company, Aditya Birla Group, traces back to 1857 when Seth Shiv Narayan Birla started a cotton trading business. His grandson, Ghanshyam Das Birla, expanded into critical sectors like chemicals and textiles. The group's international expansion was spearheaded by Aditya Vikram Birla, who established the first overseas company in Thailand in 1969. Today, under the chairmanship of Kumar Mangalam Birla, the Aditya Birla Group is a multinational corporation headquartered in Mumbai, India, with interests spanning numerous sectors.

The Epotec business manufactures and markets a comprehensive portfolio of epoxy products, including liquid and solid epoxy resins, epoxy phenol novolac (EPN) resins, reactive diluents, and curing agents. These products serve as foundational materials for formulated systems used across a wide array of industries. Clients include companies in the automotive, aerospace, marine, construction, electronics, wind energy, and industrial coatings sectors. The business model is centered on the production and global distribution of these high-performance materials, operating on a business-to-business (B2B) basis. Revenue is generated from the sale of this extensive range of epoxy resins and related systems to industrial manufacturers and formulators.

Epotec offers a broad spectrum of epoxy systems, including Bisphenol-A, Bisphenol-F, and multifunctional resins, tailored for performance. Its product lines are engineered to provide specific properties like high chemical and temperature resistance, flexibility, and strong adhesion. The brand also produces specialty items such as waterborne products, cycloaliphatic resins for UV and weather resistance, and phenalkamines derived from renewable cashew nut shells for marine and industrial coatings. A key feature is the company's collaborative approach, working with customers to develop custom formulations and solutions for mission-critical and new-age applications, supported by its R&D and application development labs.

Source: Dealroom company data

At a glance

Status
Operational
Founded
1997
Headquarters
Wilmington, United States
Open positions
None listed
Dealroom signal
19.7/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Hard Tech
Client focus
b2c

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Nov 1999 $10M $40M Sprout Group —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Epotec website traffic

Latest recorded traffic for Epotec is 0 monthly website visits.

Latest monthly visits0
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Sprout Group
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Wilmington HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Epotec on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Epotec’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.